ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Biliary Atresia Research Consortium

This study is not yet open for patient recruitment.

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Biliary Atresia Research Consortium (BARC) is to establish a database of clinical information and serum and tissue samples from children with biliary atresia (BA) and idiopathic neonatal hepatitis (INH) to facilitate research and to perform clinical, epidemiological and therapeutic trials in these two important pediatric liver diseases.

Condition
Biliary Atresia
Cholestasis

MedlinePlus related topics:  Bile Duct Diseases;   Birth Defects;   Digestive Diseases

Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study

Eligibility

Ages Eligible for Study:  up to  6 Months,  Genders Eligible for Study:  Both

Criteria

Age less or equal to 180 days at presentation to clinical site. Clinically meaningful cholestasis due to primary hepatobiliary disease.

Location Information


California
      University of California, San Francisco,  California,  94143,  United States
Philip Rosenthal, MD  415-476-5892    prosenth@peds.ucsf.edu 
Philip Rosenthal, MD,  Principal Investigator

Colorado
      The Children's Hospital, Denver,  Colorado,  80218,  United States
Ronald Sokol, MD  303-861-6669    sokol.ronald@tchden.org 
Ronald Sokol, MD,  Principal Investigator
Cara Mack, MD,  Sub-Investigator
Michael Narkewicz, MD,  Sub-Investigator

Illinois
      Children's Memorial Hospital, Chicago,  Illinois,  60614,  United States
Peter Whitington, MD  773-880-4643    p-whitington@northwestern.edu 
Peter Whitington, MD,  Principal Investigator

Maryland
      Johns Hopkins School of Medicine, Baltimore,  Maryland,  21287,  United States
Kathleen Schwarz, MD  410-955-8769    kschwarz@jhmi.edu 
Kathleen Schwarz, MD,  Principal Investigator
Patricia DeRusso, MD,  Sub-Investigator

Missouri
      Washington University School of Medicine, St. Louis,  Missouri,  63110,  United States
Ross Shepherd, MD  314-454-2337    shepherd_r@kids.wustl.edu 
Robert Heukeroth, MD,  Sub-Investigator

New York
      Mount Sinai Medical Center, New York City,  New York,  10029,  United States
Benjamin Shneider, MD  212-241-6227    benjamin.shneider@mssm.edu 
Benjamin Shneider, MD,  Principal Investigator

Ohio
      Children's Hospital Medical Center, Cincinnati,  Ohio,  45229,  United States
Jorge Bezerra, MD  513-636-4928    jorge.bezerra@chmcc.org 
Jorge Bezerra, MD,  Principal Investigator
John Bucuvalas, MD,  Sub-Investigator

Pennsylvania
      Children's Hospital of Philadelphia, Philadelphia,  Pennsylvania,  19104,  United States
Barbara Haber, MD  215-590-3606    haber@email.chop.edu 
Barbara Haber, MD,  Principal Investigator
Elizabeth Rand, MD,  Sub-Investigator

      Children's Hospital of Pittsburgh, Pittsburgh,  Pennsylvania,  15213,  United States
David Perlmutter, MD  412-692-8071    perldav@chp.edu 
David Perlmutter, MD,  Principal Investigator

Study chairs or principal investigators

Ronald Sokol, MD,  Study Chair,  The Children's Hospital, Denver   
Patricia Robuck, PhD,  Study Director,  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)   
Morton B Brown, PhD,  Study Director,  University of Michigan, Ann Arbor   

More Information

Biliary Atresia Research Consortium website

Study ID Numbers:  BARC; U01-DK62456-01
Record last reviewed:  July 2004
Record first received:  June 5, 2003
ClinicalTrials.gov Identifier:  NCT00061828
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-10-20
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act